ABL Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	5,100,458	11,025,033	1,443,630	1,178,156	1,099,129	1,041,424
Market Cap Growth	73.72%	663.70%	22.53%	7.19%	5.54%	-
Enterprise Value	4,969,880	10,941,258	1,335,337	1,126,398	1,038,936	-
Last Close Price	91100.00	200000.00	29900.00	24600.00	23000.00	22100.00
PE Ratio	-	-	-	-	342.55	-
PS Ratio	56.47	138.94	43.22	17.97	16.33	195.31
PB Ratio	27.82	70.36	8.63	15.90	15.81	18.61
P/TBV Ratio	28.72	72.60	8.91	16.47	16.43	19.50
P/FCF Ratio	763.67	-	-	-	15.69	-
P/OCF Ratio	255.60	-	-	-	15.24	-
EV/Sales Ratio	55.02	137.89	39.98	17.18	15.44	-
EV/EBITDA Ratio	-	-	-	-	321.37	-
EV/EBIT Ratio	-	-	-	-	1144.20	-
EV/FCF Ratio	744.12	-	-	-	14.83	-
Debt / Equity Ratio	0.30	0.35	0.26	0.59	0.60	0.01
Debt / EBITDA Ratio	-	-	-	-	12.94	-
Debt / FCF Ratio	8.31	-	-	-	0.60	-
Net Debt / Equity Ratio	-0.73	-0.38	-0.58	-0.37	-0.52	-0.77
Net Debt / EBITDA Ratio	5.39	1.61	1.72	996.51	-11.28	0.88
Net Debt / FCF Ratio	-19.96	0.97	1.25	0.80	-0.52	1.03
Asset Turnover	0.36	0.31	0.17	0.38	0.54	-
Quick Ratio	1.67	1.41	2.24	1.71	1.09	5.01
Current Ratio	1.70	1.43	2.28	1.81	1.12	5.20
Return on Equity (ROE)	-14.95%	-23.38%	-46.01%	-3.69%	5.12%	-
Return on Assets (ROA)	-7.02%	-9.84%	-18.93%	-0.95%	0.45%	-
Return on Capital Employed (ROCE)	-15.50%	-25.70%	-35.20%	-2.20%	0.80%	-90.30%
Earnings Yield	-0.47%	-0.34%	-3.85%	-0.22%	0.29%	-4.18%
FCF Yield	0.13%	-0.56%	-5.43%	-2.90%	6.38%	-4.02%
Buyback Yield / Dilution	-10.68%	-7.25%	-0.37%	-0.58%	-1.27%	-